Advertisement

Surgical Management of Atrial Fibrillation

  • Kareem Bedeir
  • Basel RamlawiEmail author
Chapter
  • 7 Downloads

Abstract

Atrial fibrillation is the most common cardiac arrhythmia and is associated with significant morbidity. Medical management of atrial fibrillation is often suboptimal and is challenged by many patient-related or therapy-related difficulties. Surgical options for atrial fibrillation aim to provide an improved efficacy therapy that avoids the shortcomings of lifelong anticoagulation and anti-arrhythmic therapy and/or lifestyle change. The introduction of ablation devices has revolutionized the surgical treatment of AF making procedures available to a wider patient population.

Keywords

Ablation devices Atrial fibrillation Epicardial autonomic ganglia Sleeve transition zone Trigger 

References

  1. 1.
    Corley SD, Epstein AE, et al. Relationships between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study. Circulation. 2004;109:1509–13.PubMedCrossRefPubMedCentralGoogle Scholar
  2. 2.
    Wyse DG, Love JC, et al. Atrial fibrillation: a risk factor for increased mortality--an AVID registry analysis. J Interv Card Electrophysiol. 2001;5:267–73.PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Leong DP, Eikelboom JW, et al. Atrial fibrillation is associated with increased mortality: causation or association? Eur Heart J. 2013;34:1027–30.PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Wyse DG, Waldo AL, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825–33.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Van Gelder IC, Hagens VE, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 2002;347:1834–40.PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Calkins H, Hindricks G, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017;14:e275–444.PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Bedeir K, Giugliano RP, et al. Chronic anticoagulation in non-valvular atrial fibrillation: where things stand. Int J Cardiol. 2016;222:615–9.PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Damiano RJ Jr, Schwartz FH, et al. The Cox maze IV procedure: predictors of late recurrence. J Thorac Cardiovasc Surg. 2011;141:113–21.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Leitch JW, Klein G, et al. Sinus node-atrioventricular node isolation: long-term results with the “corridor” operation for atrial fibrillation. J Am Coll Cardiol. 1991;17:970–5.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Defauw JJ, Guiraudon GM, et al. Surgical therapy of paroxysmal atrial fibrillation with the “corridor” operation. Ann Thorac Surg. 1992;53:564–70.PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Cox JL, Schuessler RB, et al. The surgical treatment of atrial fibrillation. I. Summary of the current concepts of the mechanisms of atrial flutter and atrial fibrillation. J Thorac Cardiovasc Surg. 1991;101:402–5.PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Cox JL, Canavan TE, et al. The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation. J Thorac Cardiovasc Surg. 1991;101:406–26.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Cox JL, Schuessler RB, et al. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg. 1991;101:569–83.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Cox JL. The surgical treatment of atrial fibrillation. IV. Surgical technique. J Thorac Cardiovasc Surg. 1991;101:584–92.PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Cox JL, Schuessler RB, et al. An 8 1/2-year clinical experience with surgery for atrial fibrillation. Ann Surg. 1996;224:267–73.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Cox JL, Jaquiss RD, et al. Modification of the maze procedure for atrial flutter and atrial fibrillation. II. Surgical technique of the maze III procedure. J Thorac Cardiovasc Surg. 1995;110:485–95.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Cox JL, Ad N, et al. Current status of the Maze procedure for the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg. 2000;12:15–9.PubMedCrossRefPubMedCentralGoogle Scholar
  18. 18.
    Schaff HV, Dearani JA, et al. Cox-Maze procedure for atrial fibrillation: Mayo Clinic experience. Semin Thorac Cardiovasc Surg. 2000;12:30–7.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    McCarthy PM, Gillinov AM, et al. The Cox-Maze procedure: the Cleveland Clinic experience. Semin Thorac Cardiovasc Surg. 2000;12:25–9.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Prasad SM, Maniar HS, et al. The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures. J Thorac Cardiovasc Surg. 2003;126:1822–8.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Gaynor SL, Schuessler RB, et al. Surgical treatment of atrial fibrillation: predictors of late recurrence. J Thorac Cardiovasc Surg. 2005;129:104–11.PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Cox JL, Ad N, et al. Impact of the maze procedure on the stroke rate in patients with atrial fibrillation. J Thorac Cardiovasc Surg. 1999;118:833–40.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Pasic M, Musci M, et al. Transient sinus node dysfunction after the Cox-maze III procedure in patients with organic heart disease and chronic fixed atrial fibrillation. J Am Coll Cardiol. 1998;32:1040–7.PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Damiano RJ Jr, Bailey M, et al. Multimed Man Cardiothorac Surg. 2007;2007(723):mmcts 2007.002758.PubMedPubMedCentralGoogle Scholar
  25. 25.
    Gaynor SL, Ishii Y, et al. Successful performance of Cox-Maze procedure on beating heart using bipolar radiofrequency ablation: a feasibility study in animals. Ann Thorac Surg. 2004;78:1671–7.PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Gaynor SL, Diodato MD, et al. A prospective, single-center clinical trial of a modified Cox maze procedure with bipolar radiofrequency ablation. J Thorac Cardiovasc Surg. 2004;128:535–42.PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Damiano RJ, Gaynor SL. Atrial fibrillation during mitral valve surgery using the Atricure Device. Oper Tech Thorac Cardiovasc Surg. 2004;9:24–33.CrossRefGoogle Scholar
  28. 28.
    Doll N, Kornherr P, et al. Epicardial treatment of atrial fibrillation using cryoablation in an acute off-pump sheep model. Thorac Cardiovasc Surg. 2003;51:267–73.PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Weimar T, Bailey MS, et al. The Cox-maze IV procedure for lone atrial fibrillation: a single center experience in 100 consecutive patients. J Interv Card Electrophysiol. 2011;31:47–54.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Lall SC, Melby SJ, et al. The effect of ablation technology on surgical outcomes after the Cox-maze procedure: a propensity analysis. J Thorac Cardiovasc Surg. 2007;133:389–96.PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Haissaguerre M, Jais P, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659–66.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Bagge L, Blomstrom P, et al. Epicardial off-pump pulmonary vein isolation and vagal denervation improve long-term outcome and quality of life in patients with atrial fibrillation. J Thorac Cardiovasc Surg. 2009;137:1265–71.PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Han FT, Kasirajan V, et al. Results of a minimally invasive surgical pulmonary vein isolation and ganglionic plexi ablation for atrial fibrillation: single-center experience with 12-month follow-up. Circ Arrhythm Electrophysiol. 2009;2:370–7.PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Edgerton JR, Brinkman WT, et al. Pulmonary vein isolation and autonomic denervation for the management of paroxysmal atrial fibrillation by a minimally invasive surgical approach. J Thorac Cardiovasc Surg. 2010;140:823–8.PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Gaita F, Riccardi R, et al. Linear cryoablation of the left atrium versus pulmonary vein cryoisolation in patients with permanent atrial fibrillation and valvular heart disease: correlation of electroanatomic mapping and long-term clinical results. Circulation. 2005;111:136–42.PubMedCrossRefGoogle Scholar
  36. 36.
    Ramlawi B, Bedeir K. Surgical options in atrial fibrillation. J Thorac Dis. 2015;7:204–13.PubMedPubMedCentralGoogle Scholar
  37. 37.
    Gillinov AM, Gelijns AC, et al. Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med. 2015;372:1399–409.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Barnett SD, Ad N. Surgical ablation as treatment for the elimination of atrial fibrillation: a meta-analysis. J Thorac Cardiovasc Surg. 2006;131:1029–35.PubMedCrossRefPubMedCentralGoogle Scholar
  39. 39.
    Boersma LV, Castella M, et al. Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial. Circulation. 2012;125:23–30.PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Kearney K, Stephenson R, et al. A systematic review of surgical ablation versus catheter ablation for atrial fibrillation. Ann Cardiothorac Surg. 2014;3:15–29.PubMedPubMedCentralGoogle Scholar
  41. 41.
    Pison L, La Meir M, et al. Hybrid thoracoscopic surgical and transvenous catheter ablation of atrial fibrillation. J Am Coll Cardiol. 2012;60:54–61.PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Muneretto C, Bisleri G, et al. Durable staged hybrid ablation with thoracoscopic and percutaneous approach for treatment of long-standing atrial fibrillation: a 30-month assessment with continuous monitoring. J Thorac Cardiovasc Surg. 2012;144:1460–5.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    La Meir M, Gelsomino S, et al. The hybrid approach for the surgical treatment of lone atrial fibrillation: one-year results employing a monopolar radiofrequency source. J Cardiothorac Surg. 2012;7:71.PubMedPubMedCentralCrossRefGoogle Scholar
  44. 44.
    Bisleri G, Rosati F, et al. Hybrid approach for the treatment of long-standing persistent atrial fibrillation: electrophysiological findings and clinical results. Eur J Cardiothorac Surg. 2013;44:919–23.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Wolf PA, Abbott RD, et al. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983–8.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Stollberger C, Chnupa P, et al. Mortality and rate of stroke or embolism in atrial fibrillation during long-term follow-up in the embolism in left atrial thrombi (ELAT) study. Clin Cardiol. 2004;27:40–6.PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Onalan O, Lashevsky I, et al. Nonpharmacologic stroke prevention in atrial fibrillation. Expert Rev Cardiovasc Ther. 2005;3:619–33.PubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    Rosendaal FR, Cannegieter SC, et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69:236–9.PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.
    Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: stroke prevention in atrial fibrillation III randomised clinical trial. Lancet. 1996;348:633–8.Google Scholar
  50. 50.
    Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61:755–9.PubMedCrossRefPubMedCentralGoogle Scholar
  51. 51.
    Garcia-Fernandez MA, Perez-David E, et al. Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study. J Am Coll Cardiol. 2003;42:1253–8.PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    Almahameed ST, Khan M, et al. Left atrial appendage exclusion and the risk of thromboembolic events following mitral valve surgery. J Cardiovasc Electrophysiol. 2007;18:364–6.PubMedCrossRefPubMedCentralGoogle Scholar
  53. 53.
    Bando K, Kobayashi J, et al. Early and late stroke after mitral valve replacement with a mechanical prosthesis: risk factor analysis of a 24-year experience. J Thorac Cardiovasc Surg. 2003;126:358–64.PubMedCrossRefPubMedCentralGoogle Scholar
  54. 54.
    Bedeir K, Holmes DR, et al. Left atrial appendage exclusion: an alternative to anticoagulation in nonvalvular atrial fibrillation. J Thorac Cardiovasc Surg. 2017;153:1097–105.PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    Holmes DR, Reddy VY, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374:534–42.PubMedCrossRefPubMedCentralGoogle Scholar
  56. 56.
    Reddy VY, Doshi SK, et al. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) trial. Circulation. 2013;127:720–9.PubMedCrossRefPubMedCentralGoogle Scholar
  57. 57.
    Reddy VY, Sievert H, et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA. 2014;312:1988–98.PubMedCrossRefPubMedCentralGoogle Scholar
  58. 58.
    Bartus K, Han FT, et al. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. J Am Coll Cardiol. 2013;62:108–18.PubMedCrossRefPubMedCentralGoogle Scholar
  59. 59.
    Massumi A, Chelu MG, et al. Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation. Am J Cardiol. 2013;111:869–73.PubMedCrossRefPubMedCentralGoogle Scholar
  60. 60.
    Stone D, Byrne T, et al. Early results with the LARIAT device for left atrial appendage exclusion in patients with atrial fibrillation at high risk for stroke and anticoagulation. Catheter Cardiovasc Interv. 2015;86:121–7.PubMedCrossRefPubMedCentralGoogle Scholar
  61. 61.
    Salzberg SP, Plass A, et al. Left atrial appendage clip occlusion: early clinical results. J Thorac Cardiovasc Surg. 2010;139:1269–74.PubMedCrossRefPubMedCentralGoogle Scholar
  62. 62.
    Ailawadi G, Gerdisch MW, et al. Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial. J Thorac Cardiovasc Surg. 2011;142:1002–9, 9 e1.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Brigham and Women’s HospitalBostonUSA
  2. 2.Cardiovascular SurgeryValley Health SystemWinchesterUSA

Personalised recommendations